Argent BioPharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of nano-engineered therapeutics targeting neurological and immune-mediated disorders. It operates through the following geographical segments: Malta, Slovenia, United Kingdom (UK), and Australia. The company was founded by Roby Zomer on October 21, 2005 and is headquartered in Subiaco, Australia.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Argent Biopharma Ltd. market cap is $648,200.00.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Argent Biopharma Ltd. 52 week high is $0.0958 as of November 18, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Argent Biopharma Ltd. 52 week low is $0.0055 as of November 18, 2026.
Argent Biopharma Ltd. stock price today is $0.0055.
Argent Biopharma Ltd. stock price yesterday was $0.025.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Argent Biopharma Ltd.'s P/E ratio is -0.07.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Argent Biopharma Ltd. P/B ratio is -0.0814.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Argent Biopharma Ltd. 50-day moving average is $0.0055.